|
Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
| ||
NOT A SUBSCRIBER?Hisamitsu Pharma bags rival Noven PharmaPosted on July 14, 2009 4:43 PM
Bidding to expand in the U.S., Japanese drugmaker Hisamitsu Pharmaceutical Co. said Tuesday it would spend $428 million to acquire Noven Pharmaceuticals Inc.
Terms of the deal call for Hisamitsu to pay $16.50 in cash for each Noven share, a premium of 22% over Noven's Monday close and a 43% premium to the target's average closing price over the past 90 days. This is a free content preview. Subscribers enjoy access to all stories in full as well as second-to-none market intelligence. Dig deeper, with Pipeline.
Most searched keywords
|
|
EXISTING USERS Missing a product? |
Michael Crosby mcrosby@thedeal.com 212.313.9325 |
Martha Brown mbrown@thedeal.com 212.313.9218 |